The following slide deck was published by Meridian Bioscience, Inc. in conjunction with this Read more …
Vivo Cannabis Inc.
ABcann Medicinals Inc. was one of the first companies to obtain a production license under the Marihuana for Medical Purposes Regulations. Since 2014, we have focused on changing the face of medical cannabis. Today, every variable in our growing, curing and harvesting process is controlled and monitored by computer. This indoor, high-tech growing environment has resulted in a superior product that's clean, consistent and repeatable; qualities that physicians and patients are looking for.
Marijuana Infused Products
1d
5d
1m
6m
1y
Max
Vivo Cannabis Inc. News
07 Jun
Meridian Bioscience (VIVO) Presents At William Blair Growth Stock Conference - Slideshow
Meridian Bioscience has completed a cash acquisition of a Canadian provider of molecular diagnostic instruments and assays.
03 Jun
Meridian Bioscience Announces Closing of Transaction to Acquire Business of GenePOC
CINCINNATI, June 03, 2019 -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced it has.
20 May
Meridian Bioscience, Inc. (NASDAQ:VIVO) Earns Among The Best Returns In Its Industry
Today we are going to look at Meridian Bioscience, Inc. (NASDAQ:VIVO) to see whether it might be an attractive...
Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved, lost nearly 40% of its value at one point in 2018. Although hedge funds are not...
30 Apr
Edited Transcript of VIVO earnings conference call or presentation 30-Apr-19 2:00pm GMT
Q2 2019 Meridian Bioscience Inc Earnings Call
30 Apr
Meridian Bioscience's (VIVO) CEO Jack Kenny Q2 2019 Earnings and Strategic Acquisition Conference - Call Tr
Meridian Bioscience Inc. (VIVO) Q2 2019 Earnings and Strategic Acquisition Conference Call April 30, 2019, 10:00 AM ET Company Participants Eric Rasmussen Chief Financial Officer Jack Kenny...
One of Greater Cincinnati’s largest public companies is planning an acquisition that could have a price tag of up to $120 million.
Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 26.67% and 0.46%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
30 Apr
Meridian Bioscience Reports Second Quarter 2019 Operating Results, Suspends Quarterly Cash Dividend, and Pr
CINCINNATI, April 30, 2019 -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the second quarter and first six months ended March 31, 2019..
About Vivo Cannabis Inc.
ABcann's group of companies will be the first to produce repeatable, standardized, plant-based medicines worldwide.
ABcann will produce products with integrity in a customer focused culture where social responsibility and environmental impacts are mandated.
$ 33.97
Open:
33.97
High:
33.97
Low:
33.97
Market cap:
498.328 M
Symbol:
VIVO
Contact info
Phone:
1-855-322-2266
Address:
126 Vanluven Rd, Napanee, ON K7R 3L2, Canada
